polmacoxib
Selected indexed studies
- Polmacoxib: A Review of the Newer Non-steroidal Anti-inflammatory Drug in Osteoarthritis. (Cureus, 2024) [PMID:38765421]
- Polmacoxib 2mg in patients with mild to moderate idiopathic osteoarthritis of hip/knee-a randomized, double-anonymous study. (Pain Manag, 2024) [PMID:39545640]
- Review of Safety and Efficacy of Polmacoxib: A Novel Dual Inhibitor of Cyclo-oxygenase 2 and Carbonic Anhydrase in Osteoarthritis and Acute Painful Conditions. (J Assoc Physicians India, 2025) [PMID:41100334]
_Worker-drafted node — pending editorial review._
Connections
polmacoxib is a side effect of
Sources
- Polmacoxib: A Review of the Newer Non-steroidal Anti-inflammatory Drug in Osteoarthritis. (2024) pubmed
- Polmacoxib 2mg in patients with mild to moderate idiopathic osteoarthritis of hip/knee-a randomized, double-anonymous study. (2024) pubmed
- Review of Safety and Efficacy of Polmacoxib: A Novel Dual Inhibitor of Cyclo-oxygenase 2 and Carbonic Anhydrase in Osteoarthritis and Acute Painful Conditions. (2025) pubmed
- Population Pharmacokinetic and Pharmacodynamic Analysis of Polmacoxib in Healthy Volunteers and Patients With Osteoarthritis. (2022) pubmed
- A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis. (2017) pubmed
- Bioanalytical method development for polmacoxib in rat plasma using LC-MS/MS and Its preclinical pharmacokinetic evaluation. (2025) pubmed
- Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study. (2025) pubmed
- Polypharmacology of carbonic anhydrase inhibitors and activators. (2025) pubmed
- Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649). (2016) pubmed
- An Unusual Case of Colon Perforation With Multiple Transmural Ulcers After Use of Polmacoxib and Everolimus in a Metastatic Breast Cancer Patient. (2021) pubmed